Johnson & Johnson (NYSE:JNJ) posted fourth-quarter results today that beat the consensus forecast on Wall Street — with the company predicting a return to strong sales growth in 2021. The New Brunswick, N.J.–based pharma, medical device and consumer products giant reported profits of $1.7 billion, or 65¢ per share, on sales of $22.5 billion for the […]
Johnson and Johnson
J&J touts results of robotic bronchoscopy trial
Johnson & Johnson (NYSE:JNJ) subsidiary Auris Health is touting positive results from a study of its Monarch robotic bronchoscopy system. Monarch, a first-of-its-kind robotic technology, was cleared by the FDA in March 2018 for diagnostic and therapeutic bronchoscopies. In May, Auris touted interim results from an independent feasibility study designed to assess the platform. In that study, in 82 procedures, researchers […]
DePuy Synthes lands FDA clearance for Velys robotic knee system
Johnson & Johnson (NYSE:JNJ) unit DePuy Synthes announced that it received FDA 510(k) clearance for the Velys system. Velys is a robotic-assisted system designed for use with the Attune total knee system and its cleared indications for use and it will become part of the broader Velys digital surgery platform of connected technologies, according to a news […]
Medtechs can’t set digital strategies aside – DTW Podcast
Digital connectivity no longer belongs in the final slides of a medtech company’s pitch deck. In the latest DeviceTalks Weekly podcast, three leaders pushing for connected medical devices explain the need to incorporate data collection and monitoring functionality in new devices. Scott Huennekens, who advanced the “digital surgery” strategy when he helped launch Verb Surgical, […]
MedTech 100 roundup: Industry peaks again after new vaccine authorization
Recent news in the industry continues to drive its stocks forward, with COVID-19 vaccine developments driving further medtech growth last week. The FDA granted Moderna emergency use authorization for its vaccine candidate on Friday and its rollout to the U.S. is beginning today. Moderna’s vaccine joins the one made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX), which […]
Taking the fight to COVID-19 – BD, DHL, Novant on delivering, shipping and administering the vaccine
This week’s DeviceTalks Weekly podcast shares the stories of the professionals who are working to get the new COVID-19 vaccines into the hands – and arms – of the front-line fighters and people at greatest risk. Leading off, Elizabeth Woody, SVP of public affairs at BD, explains how the company is preparing for the increasing […]
Longtime J&J exec sues for discrimination
Former Johnson & Johnson (NYSE:JNJ) executive Gina Bilotti is suing the company, alleging discrimination and verbal abuse from higher-up male executives. Nancy Erika Smith of Montclair, N.J.–based law firm Smith Mullin filed the lawsuit on behalf of Bilotti in the Superior Court of New Jersey in Essex County, according to a news release. According to the […]
MedTech 100 roundup: Industry remains strong despite slight dip
The heights of two weeks ago may not have been reached, but the medtech industry — despite a slight dip — performed well in the stock markets once again. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.99 (Nov. 20), marking a 1% downturn […]
Please pass the podcast – Enjoy a feast of insights from Spencer Stiles (Stryker) Art Collins (Explorer) and Mark Leahey (MDMA)
DeviceTalks Weekly listeners will need some gravy to digest this Thanksgiving feast-sized podcast featuring news and insights from three stellar guests in addition to two new installments of #2minutedetalks chapters from Delve Inc. and Explorer Surgical. This week we visit with… Mark Leahey, president of the Medical Device Manufacturers Association, who explains where medtech might […]
BREAKING: Johnson & Johnson finally unveils its new robot-assisted surgery system
Johnson & Johnson (NYSE:JNJ) today shared details on its surgical robotic platform that it says offers unrivaled flexibility and control compared to the rest of the market. The new system is designed with six arms to provide more control and flexibility in surgery, while its arms will be integrated into the operating table. Additionally, the platform […]
EU orders 200M J&J COVID-19 vaccine doses
Johnson & Johnson (NYSE:JNJ) announced today that its set to provide 200 million doses of its COVID-19 vaccine candidate to Europe. The European Commission, on behalf of the European Union, approved an advance purchase agreement in which J&J subsidiary Janssen Pharmaceutical, which is developing the vaccine candidate, would supply the doses to EU member states following […]
